PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors

This study is currently recruiting participants.

Verified by Rigshospitalet, Denmark, May 2008

Sponsored by:	Rigshospitalet, Denmark
Information provided by:	Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:	NCT00269373

Purpose

Is PET-CT scan better than PET or CT alone in diagnosing primary tumours in patients with unknown primary tumors? Can information obtained with PET-CT replace other clinical and radiological investigations? Is PET/CT cost-effective?

Condition	Intervention
Unknown Primary Tumor	Procedure: PET-CT

MedlinePlus related topics: CT Scans Cancer Nuclear Scans

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors

Further study details as provided by Rigshospitalet, Denmark:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	136
Study Start Date:	December 2005
Estimated Study Completion Date:	December 2008

Intervention Details:

no drugs included

Detailed Description:

Patients who fulfill the international definition of unknown primary tumors can be included, except:

Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.
Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included.
Women with adenocarcinoma in lymph nodes in the axilla will not be included.

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients with unknown tumors

Criteria

Inclusion Criteria:

Unknown primary tumors

Exclusion Criteria:

Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.
Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included
Women with adenocarcinoma in lymph nodes in the axilla will not be included

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00269373

Contacts

Contact: Gedske Daugaard, MD

45-35-454-677

gedske.daugaard@rh.regionh.dk

Locations

Denmark
Rigshospitalet	Recruiting
Copenhagen, Denmark, 2100
Principal Investigator: Gedske Daugaard, MD

Sponsors and Collaborators

Rigshospitalet, Denmark

Investigators

Principal Investigator:

Gedske Daugaard

Rigshospitalet, Denmark

More Information

Responsible Party:	Rigshospitalet ( Gedske Daugaard )
Study ID Numbers:	01 283694
Study First Received:	December 22, 2005
Last Updated:	May 20, 2008
ClinicalTrials.gov Identifier:	NCT00269373
Health Authority:	Denmark: Ethics Committee

Keywords provided by Rigshospitalet, Denmark:

Unknown primary tumor
PET-CT

Study placed in the following topic categories:

Neoplasms, Unknown Primary
Neoplasm Metastasis

Additional relevant MeSH terms:

Neoplasms
Neoplastic Processes
Pathologic Processes

ClinicalTrials.gov processed this record on January 16, 2009